Montelukast: UK regulator says asthma drug needs clearer warnings of side effects

BMJ. 2024 May 8:385:q1048. doi: 10.1136/bmj.q1048.
No abstract available

Publication types

  • News

MeSH terms

  • Acetates* / adverse effects
  • Acetates* / therapeutic use
  • Anti-Asthmatic Agents* / adverse effects
  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Cyclopropanes* / therapeutic use
  • Drug Labeling
  • Humans
  • Quinolines* / adverse effects
  • Quinolines* / therapeutic use
  • Sulfides*
  • United Kingdom

Substances

  • montelukast
  • Cyclopropanes
  • Quinolines
  • Sulfides
  • Acetates
  • Anti-Asthmatic Agents